Cellect Biotechnology
$0.52659876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.5265
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.009 (-1.68%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours
Why Robinhood?
You can buy or sell APOP and other stocks, options, ETFs, and crypto commission-free!
About APOP
Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. Read More The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. Cellect Biotechnology was founded by Kasbian Nuriel Chirich, Shai Yarkoni and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.
CEO
Employees
28
Headquarters
Kfar Saba, Jerusalem
Founded
1986
Market Cap
3.00M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.33M
High Today
$0.55
Low Today
$0.51
Open Price
$0.5419
Volume
54.74K
52 Week High
$6.01
52 Week Low
$0.4025
Collections
APOP News
Price Paid on Robinhood
67% Lower
Right Now
52 Week Low
$0.8505
Average Price Paid
$1.61
52 Week High
$7.80
APOP Earnings
-$0.19
-$0.17
-$0.15
-$0.13
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
—